Abstract
Morphine influences multiple brain nuclei that regulate key physiological systems, including the endocrine and immune systems, as well as behavioral expression. Opioid consumption has been shown to suppress both the hypothalamic-pituitary-adrenal (HPA) axis and immune function—systems that play a critical role in the development of opioid tolerance and the manifestation of withdrawal symptoms. Evidence from animal studies indicates that immune suppression can prevent naloxone-precipitated behavioral withdrawal in opioid-dependent subjects, suggesting that both dependence and withdrawal are mediated, at least in part, by neuroendocrine and immune mechanisms. Early research proposed that the central nervous system (CNS) modulates immune responses, aligning with the anti-inflammatory properties of opioids. In experiments where the immune system was ablated via irradiation, chronic morphine exposure failed to induce withdrawal symptoms upon naloxone administration. Conversely, restoring immune function through donor cell transplantation reinstated typical withdrawal behaviors. Notably, a single administration of cortisol—an immunomodulatory hormone—prior to chronic morphine exposure or in morphine-dependent animals significantly reduced the severity of behavioral withdrawal symptoms. Collectively, these findings highlight a bidirectional interaction between the nervous and immune systems in regulating opioid dependence and withdrawal, pointing to potential therapeutic strategies for mitigating addiction and relapse.
Keywords
Opiate, Addiction, Withdrawal, Treatment, Cortisol